New hope for pancreatic cancer recurrence: targeted radiation trial underway

NCT ID NCT04881487

First seen May 11, 2026 · Last updated May 11, 2026

Summary

This study tests whether adding targeted radiation therapy (SBRT) to standard care helps people with pancreatic cancer that has returned only in the original area live longer and feel better. About 174 adults whose cancer came back after surgery will be randomly assigned to get SBRT plus usual care or usual care alone. The main goal is to see if SBRT extends survival after recurrence, while also tracking quality of life and side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT PANCREATIC DUCTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Amsterdam University Medical Center, VUmc

    RECRUITING

    Amsterdam, North Holland, 1081 HV, Netherlands

    Contact

    Contact

    Contact Email: •••••@•••••

  • Erasmus University Medical Center

    RECRUITING

    Rotterdam, South Holland, 3015 GD, Netherlands

    Contact

    Contact

    Contact Email: •••••@•••••

  • University Medical Center Utrecht

    RECRUITING

    Utrecht, Utrecht, 3584 CX, Netherlands

    Contact

    Contact

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.